Maverick Capital’s Viridian Therapeutics VRDN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.6M | Buy |
2,257,010
+195,736
| +9% | +$2.74M | 0.47% | 45 |
|
|
2025
Q1 | $27.8M | Buy |
2,061,274
+7,368
| +0.4% | +$99.3K | 0.49% | 48 |
|
|
2024
Q4 | $39.4M | Buy |
2,053,906
+56,753
| +3% | +$1.09M | 0.71% | 43 |
|
|
2024
Q3 | $45.4M | Sell |
1,997,153
-1,310,792
| -40% | -$29.8M | 0.89% | 37 |
|
|
2024
Q2 | $43M | Buy |
3,307,945
+615,531
| +23% | +$8.01M | 0.82% | 39 |
|
|
2024
Q1 | $47.1M | Buy |
2,692,414
+366,573
| +16% | +$6.42M | 0.89% | 36 |
|
|
2023
Q4 | $50.7M | Buy |
+2,325,841
| New | +$50.7M | 1.02% | 31 |
|